Explore of Minimal clinically important differences (MCID) of the Scale for the Assessment and Rating of Ataxia (SARA) and the Vertigo Symptom Scale- short form (VSS-sf) in stroke. A multicenter prospective observational study.

Explore of Minimal clinically important differences (MCID) of the Scale for the Assessment and Rating of Ataxia (SARA) and the Vertigo Symptom Scale- short form (VSS-sf) in stroke. A multicenter prospective observational study. - Explore of Minimal clinically important differences (MCID) of the Scale for the Assessment and Rating of Ataxia (SARA) and the Vertigo Symptom Scale- short form (VSS-sf) in stroke. A multicenter prospective observational study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049620

Enrollment

120

Registered

2022-12-01

Start date

2023-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Stroke, Infratentorial CI or ICH (2)ataxia (SARA>0) (3)no/some palsy and sensory disturbance"

Exclusion criteria

Exclusion criteria: (1) before this stroke, modified Rankin Scale : mRS=>2 (2) Mini Mental State Examination-J (MMSE-J) <= 23 (3) dropout from rehabilitation program

Design outcomes

Primary

Measure	Time frame
Scale for the Assessment and Rating of Ataxia	—

Secondary

Measure	Time frame
Vertigo Symptom Scale- short form	—

Countries

Japan

Contacts

Public ContactShota Yoshikawa

Sakurakai Hospital Department of Rehabilitation

s8t4y6k3@gmail.com072-366-5757

Outcome results